Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.55 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.55 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.55 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.55 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.55 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.55 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL27718975 | 0.98 | CA12 (0.55) | CA12CA1CA2CA9ALOX12 | |
| Iodide SCHEMBL28867266 | 0.98 | CA12 (0.55) | CA12CA1CA2CA9ALOX12 | |
| Hydrochloric Acid SCHEMBL3065003 | 0.98 | CA12 (0.55) | CA12CA1CA2CA9ALOX12 | |
| Bicarbonate SCHEMBL27358699 | 0.94 | CYP2D6 (0.56) | CA12CA1CA2CA9ALOX12 | |
| Acetic Acid SCHEMBL28068598 | 0.90 | CYP2C9 (0.53) | CA12CA1CA2CA9ALDH1A1 | |
| Sulfuric Acid SCHEMBL11336623 | 0.90 | GAA (0.49) | CA12CA1CA2CA9ALOX12 | |
| Sulfuric Acid SCHEMBL4014385 | 0.90 | GAA (0.49) | CA12CA1CA2CA9ALOX12 | |
| SCHEMBL3672272 | 0.88 | CYP2C9 (0.48) | CA12CA1CA2CA9ALOX12 | |
| SCHEMBL17198935 | 0.88 | ALDH1A1 (0.54) | CA12CA1CA2CA9ALOX12 | |
| SCHEMBL21947973 | 0.87 | TSHR (0.52) | CA12CA1CA2CA9ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 998 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731195-A1 | ANTAGONISTS OF THE IMIDAZOLINE-1 RECEPTOR FOR USE IN THE PREVENTION AND/OR TREATMENT OF AN AUTOINFLAMMATORY OR AUTOIMMUNE DISEASE | Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) (ES) | 2026-04-29 | — | — | EP | claimed |
| WO-2025101904-A1 | NOREPINEPHRINE TRANSPORTER-TARGETED PRODRUGS FOR CANCER THERAPY | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2025-05-15 | — | — | WO | claimed |
| CN-119950749-A | Polymer-based macromolecular prodrugs | 费城儿童医院 | 2025-05-09 | — | — | CN | claimed |
| US-20250129016-A1 | PHOTOREDOX METHODS FOR RADIOCYANATION OF ARENES AND USE THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2025-04-24 | — | — | US | claimed |
| WO-2025002914-A1 | ANTAGONISTS OF THE IMIDAZOLINE-1 RECEPTOR FOR USE IN THE PREVENTION AND/OR TREATMENT OF AN AUTOINFLAMMATORY OR AUTOIMMUNE DISEASE | CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.) (ES) | 2025-01-02 | — | — | WO | claimed |
| CN-113557037-B | Radiopharmaceuticals for diagnostic/therapeutic use in nuclear medicine and radioguided medicine | 罗马大学 | 2024-08-09 | — | — | CN | claimed |
| EP-3773540-B1 | COMPOSITION AND METHOD FOR DUAL TARGETING IN TREATMENT OF NEUROENDOCRINE TUMORS | NANOPHARMACEUTICALS LLC (US) | 2024-07-03 | — | — | EP | claimed |
| EP-4351650-A1 | COMPOSITION AND METHOD FOR DUAL TARGETING IN TREATMENT OF NEUROENDOCRINE TUMORS | NanoPharmaceuticals LLC (US) | 2024-04-17 | — | — | EP | claimed |
| CN-117412772-A | Compositions and methods for dual targeted treatment of neuroendocrine tumors | 纳米药业有限责任公司 | 2024-01-16 | — | — | CN | claimed |
| CN-116422109-A | Self-extraction layered carbon dioxide trapping system and method | 嘉兴市碳捕手科技有限责任公司 | 2023-07-14 | — | — | CN | claimed |
| EP-1185316-A1 | DEVICES AND COMPOUNDS FOR TREATING ARTERIAL RESTENOSIS | Cardio Vascular Solutions Inc. (CA) | 2002-03-13 | — | — | EP | claimed |
| WO-2002014270-A1 | NEW AMIDINO DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS | ASTRAZENECA AB (SE) | 2002-02-21 | — | — | WO | claimed |
| WO-2001029023-A1 | BENZOPYRANYL GUANIDINE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2001-04-26 | — | — | WO | claimed |
| EP-1085859-A1 | WOUND TREATMENT THROUGH INHIBITION OF ADENOSINE DIPHOSPHATE RIBOSYL TRANSFERASE | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2001-03-28 | — | — | EP | claimed |
| WO-2000074742-A1 | DEVICES AND COMPOUNDS FOR TREATING ARTERIAL RESTENOSIS | CARDIO VASCULAR SOLUTIONS INC. (CA) | 2000-12-14 | — | — | WO | claimed |
| WO-2000009115-A1 | GRP RECEPTOR LIGANDS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-02-24 | — | — | WO | claimed |
| WO-1999063982-A1 | WOUND TREATMENT THROUGH INHIBITION OF ADENOSINE DIPHOSPHATE RIBOSYL TRANSFERASE | UNIVERSITY OF MEDICINE & DENTISTRY OF NEW JERSEY (US) | 1999-12-16 | — | — | WO | claimed |
| CN-1083473-A | New imidazolium compounds and pharmaceutical composition thereof | SMITHKLINE BEECHAM CORP (US) | 1994-03-09 | — | — | CN | claimed |
| EP-0165630-B1 | METHOD OF PREPARING A CHLORINATED, BROMINATED, RADIOBROMINATED, IODINATED AND/OR RADIOIODINATED, AROMATIC OR HETEROAROMATIC COMPOUND, AS WELL AS A KIT FOR PREPARING A DIAGNOSTIC COMPOSITION ON THE BASIS OF THIS COMPOUND | MALLINCKRODT, INC.(a Missouri corporation) (US) | 1989-10-18 | — | — | EP | claimed |
| EP-0165630-A2 | Method of preparing a chlorinated, brominated, radiobrominated, iodinated and/or radioiodinated, aromatic or heteroaromatic compound, as well as a kit for preparing a diagnostic composition on the basis of this compound | MALLINCKRODT, INC.(a Missouri corporation) (US) | 1985-12-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129016-A1 | PHOTOREDOX METHODS FOR RADIOCYANATION OF ARENES AND USE THEREOF | RCC2, PPOX, FTO | CA12 165/4885CA1 425/4885CA2 256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.